Abstract: 20
Polycystic Ovary Syndrome (PCOS), the most common endocrine condition in women, is 21 often anecdotally associated with binge eating behaviours and food cravings; however there 22 is a paucity of research. This study aimed to report the prevalence of binge eating and food 23 cravings and their relation to obesity risk in women with PCOS. Participants completed an 24 online survey including the Bulimia Investigatory Test, Edinburgh, Food Cravings-Trait 25
Questionnaire and the Three Factor Eating Questionnaire revised-18. The study included 26 obese (n=340), overweight (n=70) and lean (n=45) women with PCOS and lean healthy 27 women (n=40). Sixty percent of obese women with PCOS were categorised with binge-28 eating behaviour, with 39% presenting with clinically significant behaviour. Obese women 29 with PCOS presented with high mean food cravings-trait scores (131.6±28.9) that were 30 significantly greater compared with lean (114.0±34.9) and overweight women with PCOS 31 (120.1±29.5; p<0.001). Multiple regression exploring relations between eating styles and 32 adiposity explained 59% of the variance in binge eating symptom scores in women with 33 PCOS (F =173.8; p<0.001, n=463): significant predictors were food cravings total score 34 (beta =0.52; p<0.001), emotional eating score (beta =0.16; p<0.001), BMI (beta= 0.13; 35 p<0.001) and uncontrolled eating score (beta =0.10; p<0.01). Compared with lean healthy 36 women, lean women with PCOS exhibited significantly higher binge eating symptom scores 37 (10.9±7.8 versus 7.4±6.0; p<0.05), though similar total food craving scores (114.0±34.9 38 versus 105.6±26.6: NS). This study is the largest, to date, to robustly report that a high 39 proportion of women with PCOS exhibit binge eating behaviours. We recommend screening 40 women with PCOS for binge eating behaviours to help inform the choice of weight 41 management approach for this clinical population. 42
Introduction 52 53
Polycystic ovary syndrome (PCOS) is the most common endocrine condition in women, 54 affecting up to 18% of women (1) and is characterised by a heterogeneous presentation of 55 hyperandrogenism and ovulatory dysfunction. Women with PCOS have a greater insulin 56 resistance, risk of developing type 2 diabetes (2), and a greater risk of being overweight and 57 obese compared with healthy controls (BMI >30 RR 2.77 (95% CI 1.88 to 4.10) (3). Obesity 58 significantly worsens all metabolic and reproductive outcomes for women with PCOS (4), 59
though importantly as little as 5% weight loss has been shown to improve reproductive, 60 metabolic and clinical markers (5, 6). Weight management through lifestyle modification is 61 the first line treatment within international guidelines for the management of PCOS (7-11), 62 although the effectiveness of such treatments is limited. 63
64
Binge eating has been shown to predict excess weight gain (12), obesity onset (13), weight 65 regain after dieting (14) and failed weight loss (15). Binge eating behaviour is characterized 66 by: (i) eating, in a discrete period of time, an amount of food that is definitely larger than 67 most people would eat in a similar period of time under similar circumstances; and (ii) a 68 sense of lack of control over eating (16). There is a paucity of studies exploring disordered 69 eating behaviours in women with PCOS; small studies have indicated a higher prevalence of 70 PCOS in patients with eating disorders (17, 18). There are also reports suggesting both that 71 disordered eating and bulimia nervosa are more common among women with PCOS (19-72 21), though others have reported no difference (22). Furthermore, a meta-analysis showed 73 an increased prevalence of depression and anxiety associated with PCOS compared with 74 controls (23, 24), and it is known that negative emotions are a key predictor of binge eating 75 (25, 26). Binge eating is positively associated with hyperandrogenism (27) and amenorrhea 76 (28), with hyperandrogenism implicated within the pathogenesis of anovulation and 77 menstrual irregularities (29, 30). The role of circulating testosterone concentrations in the 78 aetiology of eating disorders has yet to be fully elucidated (31). Elevated testosterone 79 concentrations may promote bulimic behaviours by influencing food cravings and impulse 80 control (31, 32). A suggestion supported by the observation that anti androgenic treatment 81 reduces bulimic behaviour (33). An alternative hypothesis is that recurrent binge eating may 82 increase insulin levels, which, via decreased concentrations of sex hormone binding 83 globulin, increase free circulating testosterone(34), ultimately negatively impacting upon 84 follicular maturation and ovulation (28). 85
86
Food cravings and obesity are positively correlated (35, 36) with evidence that individuals 87 who are obese have higher frequencies of food cravings than healthy weight individuals (37). 88
Food cravings may also discriminate between successful and unsuccessful dieters (38, 39). 89
Recently, it has been reported that food craving was identified as a significant partial 90 mediator in the relationships between elevated BMI and binge eating episodes (40). A food 91 craving has been defined as an intense desire directed at a specific food or drink that is hard 92 to resist (41). Craved and binged foods usually have a high energy density and fat content 93 (42, 43) and previous studies have reported strong associations between cravings and 94 intake of high-fat foods, sweets, and fast-food (44, 45). Food cravings are often anecdotally 95 reported by women with PCOS (46); and a pilot study indicated women with PCOS had 96 significantly higher Food Cravings-Trait scores compared with healthy women (47). 97
Raised androgens and menstrual disturbances have been associated with greater food 98 cravings in women without PCOS (48). The underlying mechanism for the relationship is 99 unclear; although circulating testosterone has been shown to stimulate appetite (49) and is 100 associated with impaired impulse control, irritability and depression (32, 50). Accordingly, it 101 has been proposed that elevated levels of androgens may promote food cravings (51). 102
103
There is an inadequate understanding of eating behaviours in women with PCOS. If binge 104 eating and food cravings are common in this group, this needs to be highlighted to help 105 clinicians focus on appropriate interventions and strategies to promote weight loss. Weight 106 loss has already been identified as a key treatment for reproductive and metabolic outcomes 107 for women with PCOS, but one which women report difficulty achieving. This study aims to 108 report the prevalence of binge eating and food cravings and their relation to obesity risk in 109 women with PCOS. It is hypothesised that a high proportion of binge eating and food craving 110 behaviours will be identified. 111 112
Methods 113

Participants 114
The study recruited 583 women with PCOS and 95 women without PCOS (Figure 1) . 115
Healthy lean women were matched for weight, age and ethnicity to lean women with PCOS. 116
Recruitment of study participants utilised social media sites and email advertisements at the 117 University of Surrey. Participant eligibility was determined by a screening questionnaire. All 118 women were at least 18 years of age. Participants were excluded if they were pregnant or 119 breastfeeding. For women with PCOS, a diagnosis of PCOS by a healthcare professional 120 was required. All overweight and obese women with PCOS were invited to participate in the 121 'Dieting experience' survey. Ethical approval was granted by the procedures of the 122 
130
Assessments and measurements 131
The online survey was presented on the Bristol Online Survey and SurveyMonkey® 132 platforms. Informed consent procedures were embedded into the survey. Participants were 133 asked questions relating to PCOS diagnosis, other medical conditions, self-reported PCOS 134 symptoms, weight, height and dieting history similar to a previous study (52). Amenorrhea 135 was considered present if participants provided a negative response to "have you had a 136 period in the previous 12 months?" 137
138
The following validated questionnaires were used: 139
i) The Bulimia Investigatory Test, Edinburgh, (BITE) (53); recognised for its validity and 140 reliability (54), is a 33-item self-report measure designed to identify individuals with 141 symptoms of bulimia or binge eating. It consists of a symptom scale and a severity scale, 142 which provides an index of the severity of binging and purging behaviour as defined by their 143
frequency. 144
ii) The Food Cravings Questionnaire-Trait (FCQ-T), a 39-item self-report questionnaire 145 whereby participants indicate how frequently each statement 'would be true for you in 146 general' using a 6-point scale [range: 1 ('never or not applicable') to 6 ('always')]. Nine trait 147 craving domains (Table 2) The dieting experience survey for overweight and obese women with PCOS included items 155 assessing dieting circumstances and perception of dieting strategies through an online 156 questionnaire previously published by (59, 60). 157 158
Data analysis 159
Frequencies and descriptive statistics were generated using IBM® Statistical Package for were used to control for body mass index (BMI). Multiple regression analysis with predictor 167 values entered simultaneously was used to explore variance of binge eating behaviours, as 168 measured by BITE symptom score; independent variables were total food cravings trait 169 score, BMI, uncontrolled eating and emotional eating scores from TFEQ-R18. 170 171
Results 172
Population characteristics 173
The majority of women with PCOS were obese (73.4%; n=340), 15.1% (n=70) were 174 overweight and 9.7 % (n=45) were lean. Women with PCOS had a mean ± SD weight of 175 98.6± 27.4kg (n=460) and BMI of 36.0±9.1 kgm -2 (n=458). The majority of participants were 176
Caucasian (84.7%), with 3.9% mixed race, 2.6% Black, 2.2% Asian and 6.7% classified as 177 'other'. Responses were from North America (n=303), Europe (n=107), Australasia (n=36) 178 and other continents (n=17 
192
Food cravings in women with PCOS 193
Nearly all of the women with PCOS self-reported craving foods (99%); these included 194 savoury and sweet, energy dense, high carbohydrate and high fat foods. BMI groups differed 195 in FCQ-T scores (one-way ANOVA group effect, F(2, 452) = 10.0 p <0.001); multiple 196 comparisons between groups (Bonferroni-adjusted) confirmed that obese women had 197 significantly higher trait food craving scores than either lean (p=0.001) or overweight 198 (p=0.01) women with PCOS (Table 2) 
241
Significant difference in proportion of binge eating symptoms between BMI groups ( 2 p<0.001,
242
Cramer's V =0.25).
244
Similar to the results for reported food-cravings, sub-groups created according to the 245 presence or absence of specific symptoms (hirsutism, depression or irregular menses) did 246 not show different binge eating symptom scores. However once again, women who reported 247 acne (n=257) had higher binge eating symptom scores (16.0±7 versus 13.6±7; p=0.01, 248
Cohen's d =0.32) than those without (n=206), likewise those who reported amenorrhea 249 
261
Emotional eating, cognitive restraint and uncontrolled eating scores in women 262
with PCOS 263
Emotional eating scores were higher in obese compared with lean women with PCOS 264 (obese 2.7±0.8, overweight 2.5±0.8 and lean 2.3±0.9; p=0.006, eta squared =0.021, post 265 hoc obese versus lean p=0.013; score ranges from 1-4). Emotional eating scores were 266 positively associated with total food craving score (r=0.74; p<0.001) and binge eating 267 symptom score (r=0.64, p<0.001). These strong correlations remained when controlled for 268 BMI. Conversely, cognitive restraint scores were lower in obese compared with lean women 269 with PCOS (obese 2.5±0.7, overweight 2.7±0.8 and lean 2.8±0.8; p=0.001, eta squared 270 =0.027, post hoc obese versus lean p=0.004). Weak negative associations were observed 271 between cognitive restraint scores and total food craving score (r=-0.23, p<0.001) and binge 272 eating symptom score (r=-0.15, p=0.01), although when controlled for the influence of BMI 273 only the weak correlation with food cravings remained (r=-0.2, p<0.001). There was a trend 274 towards greater uncontrolled eating scores in obese women with PCOS (obese 2.6±0.4, 275 overweight; 2.5±0.4 and lean 2.5±0.5; p=0.053). Uncontrolled eating scores were positively 276 associated with total food craving score (r=0.67; p<0.001) and binge eating symptom score 277 (r=0.56, p<0.001). These strong correlations remained when controlled for BMI. 278 279
Association between binge eating and food cravings in women with PCOS 280
Binge eating symptom score and food cravings total scores were strongly correlated 281 (r=0.745; p<0.001, n=463 women with PCOS. Multiple regression analysis to predict 282 contribution to binge eating symptom score included BMI, total food cravings score, 283 uncontrolled, emotional and cognitive restraint eating scores as predictor variables. The 284 model explained 57% of the variance in binge eating symptom scores (F(df1, df2)=130.4; 285 p<0.001): food cravings total score (beta =0.53; p<0.001), emotional eating score (beta 286 =0.18; p<0.001), BMI (beta= 0.11; p<0.001) and uncontrolled eating score (beta =0.09 287 p=0.02) independently contributed to this explained variance, whereas cognitive restraint 288
was not an independent predictor (beta 0.03; p=0.28). 289 290
Comparisons between lean healthy women and lean women with PCOS 291
Lean healthy women (n=40) and lean women with PCOS (n=45) were similar in ethnicity 292 (both >95% Caucasian), age (28.3±8.5 years and 31.3±5.6 years; p=0.07) and BMI 293 
314
*See Tables 2 and 3 for notes on possible scale score ranges.
316
Dieting experience in women with PCOS 317
The eating behaviours study indicated a high proportion of overweight and obese women 318 with PCOS expressed an interest in losing weight (96% and 99% respectively). Despite 319 these intentions only 47% of obese women with PCOS reported to be modifying their diet to 320 promote weight loss and a further 11% were modifying their diet to avoid weight gain (40% 321 and 11% comparatively for overweight women with PCOS). This was explored further in the 322 
Binge eating behaviour 337
The current study has reported binge eating behaviour in the majority of obese women with 338 PCOS, and more than a third of overweight and healthy weight women with PCOS. This is 339 (2014)(28). The pathogenesis is believed to involve elevated testosterone (31), we did 360 observe higher binge eating symptom scores in PCOS women with acne compared to those 361 without acne, however, scores were similar in hirsute and non-hirsute women with PCOS, 362 although it should be noted that the study was not powered to detect differences between 363 symptom sub-groups and so these results should be viewed with caution. We suggest future 364 studies explore menstrual dysfunction and hyperandrogenism in relation to eating 365 behaviours in women with PCOS including investigation of hormonal influencers in binge 366 eating (65) which was beyond the scope of this study. Another factor that may influence food cravings is dieting status, i.e. restricting energy intake 411 to lose weight: repeatedly eating palatable energy-rich food such as chocolate when hungry 412 has been shown to exacerbate craving in established chocolate cravers and induce craving 413 in previously non-cravers (43). Therefore, we examined whether trait craving or binge eating 414 scores differed by dieting status in obese women with PCOS; by and large, there were no 415 differences, with the exception that dieting women reported slightly more guilt at having 416 cravings or giving in to them, presumably because such behaviour was contrary to their 417 attempts to limit energy intake. In agreement with this, when controlled for BMI, there was 418 no correlation between cognitive restraint eating and food craving scores. 
